LymphoScan labeled antibody fragment targeted to CD22 marker on white blood cell cancers: Phase III trials

Immunomedics Inc. (IMMU), Morris Plains, N.J. Product: LymphoScan labeled antibody fragment targeted to CD22 marker on white blood cell cancers Indication: Detect non-Hodgkin's lymphoma Status: IMMU...